What is the story about?
Alkem Laboratories told the exchanges on Wednesday, December 10, that the Malta Medicines Authority carried out a GMP inspection at its Daman manufacturing facility between December 5 and December 9.
The inspection wrapped up on December 9, 2025, with no critical observations, three major observations and a few minor ones.
The company said it will address these observations within the stipulated timeline for closure.
Shares of Alkem Laboratories Ltd. are currently trading 0.071% lower on Wednesday at ₹5,663.50. The stock is up just 2% so far in 2025.
The inspection wrapped up on December 9, 2025, with no critical observations, three major observations and a few minor ones.
The company said it will address these observations within the stipulated timeline for closure.
Shares of Alkem Laboratories Ltd. are currently trading 0.071% lower on Wednesday at ₹5,663.50. The stock is up just 2% so far in 2025.
/images/ppid_59c68470-image-176551756577347029.webp)

/images/ppid_59c68470-image-176553252817472583.webp)
/images/ppid_59c68470-image-176554503501582502.webp)
/images/ppid_59c68470-image-17655050711658818.webp)
/images/ppid_59c68470-image-176547503698027658.webp)
/images/ppid_59c68470-image-176554511585420454.webp)
/images/ppid_59c68470-image-176553258995687040.webp)
/images/ppid_59c68470-image-176553503362936055.webp)
/images/ppid_59c68470-image-176551760189718608.webp)
/images/ppid_59c68470-image-1765505148835662.webp)
/images/ppid_59c68470-image-176551276144256132.webp)